For the quarter ending 2026-03-31, TCRT has $1,883K in assets. $595K in debts. $354K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 354 | 1,385 | 1,938 | 2,879 |
| Receivables | 0 | 3 | 0 | 2 |
| Prepaid expenses and other current assets, current | 616 | 600 | 747 | 857 |
| Total current assets | 970 | 1,988 | 2,685 | 3,738 |
| Property and equipment, net | 82 | 91 | 97 | - |
| Prepaid expenses and other assets, non current | 831 | 887 | 942 | 997 |
| Total assets | 1,883 | 2,966 | 3,724 | 4,735 |
| Accounts payable | 400 | 613 | 843 | 809 |
| Accrued expenses | 195 | 200 | 78 | 265 |
| Total current liabilities | 595 | 813 | 921 | 1,074 |
| Total liabilities | 595 | 813 | 921 | 1,074 |
| Preferred stock value-Series AOne Preferred Stock | 0 | 0 | 0 | 0 |
| Preferred stock value-Series ATwo Preferred Stock | 0 | 0 | 0 | 0 |
| Common stock 0.001 par value 50,000,000 shares authorized, 2,378,383 and 2,349,480 shares issued and outstanding at march 31, 2026 and at december 31, 2025, respectively | 2 | 2 | 2 | 2 |
| Additional paid-in capital | 926,914 | 926,773 | 926,530 | 926,229 |
| Accumulated deficit | -925,628 | -924,622 | -923,729 | -922,570 |
| Total stockholders' equity | 1,288 | 2,153 | 2,803 | 3,661 |
| Total liabilities and stockholders' equity | 1,883 | 2,966 | 3,724 | 4,735 |
Alaunos Therapeutics, Inc. (TCRT)
Alaunos Therapeutics, Inc. (TCRT)